NCT05590572 2022-10-21A Study of Sulfatinib on Relapsed or Refractory Drug Resistant OsteosarcomaSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 1/2 Not yet recruiting148 enrolled